Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 July 2019 | Story Ruan Bruwer | Photo Varsity Sport
Antonet Louw
Antonet Louw, star hockey player, was the leading goal scorer at the University Sport South Africa championship in Stellenbosch. She achieved the same milestone in the Varsity hockey competition in May.

Improvement by the Shimlas, men’s hockey, volleyball (men and women), and basketball teams (men and women), and stumbling over the final two hurdles by the netball and women’s hockey teams.

This, in a nutshell, was the Kovsie story at this year’s University Sport South Africa (USSA) championships that took place across the country in the first week of July.

The Shimlas improved from fourth to third place in 2019, winning two of their three encounters. The hockey men, who finished second in last year’s B Section, were unbeaten in 2019, earning them an automatic promotion to the A Section in 2020.

The men’s volleyball team improved from 11th to 6th place, the women from 15th to 5th, and the basketball men (6th) and women (9th) improved by three and one positions respectively.

For a large part of the netball and women’s hockey tournaments, it looked very promising that one or both of the UFS teams could go all the way.

The netball team has won all five of their group matches, including victories over the North-West University (NWU) and Tuks, against whom they lost in the play-off fixtures on the final two days.

Another milestone by Antonet
This was also the case with the women’s hockey team. They recorded wins in all three of their group matches, including a 3-0 win over the Maties, who were the Varsity hockey runners-up in May. In the semi-final, Tuks prevailed by 4-0 and in the play-off for third/fourth place, the Maties triumphed by 3-1.

Antonet Louw, the leading goal scorer during the Varsity hockey tournament, again contributed the most goals (five in five matches).

In the fencing championship, Relebohile Pule (women’s epee) and Johanco Viljoen (men’s sabre) both returned with bronze medals.

Ewald van Zyl (elite male kumite +84 kg, gold medal) and Diena Benade (elite female kumite -68 kg, gold) were the two standouts in karate.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept